We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promise of Structure-Based Drug Design for GPCRs

News   May 10, 2012

 
Promise of Structure-Based Drug Design for GPCRs
 
 
 

RELATED ARTICLES

Mastering the Tricky Task of Measuring Tiny Nanoparticles

News

Researchers have determined that measuring the range of sizes in nanoparticles — instead of just the average particle size — is optimal for most applications.

READ MORE

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

Enzyme Presents as a Target for New Sepsis Drugs

News

Researchers have found that removing the enzyme PHLPP1 improves outcomes in a mouse model of sepsis. This finding suggests that inhibiting PHLPP1 could form the basis for new sepsis treatments in humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE